A new study of college and high school football players indicates that biomarkers in the blood might have potential use in recognizing which players are more tend to need a longer revival time after a concussion. The study was published in the AAN’s (American Academy of Neurology) medical journal Neurology. Timothy B. Meier—from the MCW (Medical College of Wisconsin)—said, “With so many individuals sustaining concussions and a huge number of them dealing with prolonged symptoms and recovery, any devices we can develop to aid in determining who would be at higher risk of issues will be very beneficial, so these outcomes are a vital first step.”
The research involved 41 college and high school football players who encountered a concussion throughout the season. At that time, none of the players lost awareness with their concussions. All of the partakers had blood tests at the opening of the season. The tests analyzed levels of seven biomarkers for the inflammation, which have been related to more serious brain injury. Out of the seven biomarkers, two were raised for those with a concussion at 6 Hours following the injury in comparison to the athletes having no concussion. The biomarkers interleukin 1 and interleukin 6 receptor antagonist were raised at 6 Hours subsequent to a concussion.
On a similar note, recently, a study showed that even people with well-controlled epilepsy might be at danger for sudden death. People having epilepsy have an unusual peril of sudden death. The latest study suggests that risk might apply even to individuals whose epilepsy is well-maintained, which is different from past studies that showed the jeopardy was highest amongst those with difficult-to-treat and severe epilepsy. The new research was published in the journal Neurology. Reportedly, SUDEP (sudden unexpected death in epilepsy) with no known causes affects around 1 in 1,000 people with epilepsy every year.